Exactech (EXAC) Tops Q4 EPS by 3c, Offers Q1, FY15 Guidance

Exactech (NASDAQ: EXAC) reported Q4 EPS of $0.36, $0.03 better than the analyst estimate of $0.33. Revenue for the quarter came in at $63.3 million versus the consensus estimate of $63.3 million.

Looking forward, Exactech released its initial 2015 revenue guidance of $252-$260 million and diluted EPS target of $1.20-$1.28. For the first quarter of 2015, the company anticipates USGAAP revenues of $62-$65 million and diluted EPS of $0.30-$0.32. The foregoing statements regarding targets for the quarter and full year are forward-looking and actual results may differ materially. These are the company’s targets, not predictions of actual performance.

(Street sees Q1 EPS of $0.31 and FY EPS of $1.28)

For earnings history and earnings-related data on Exactech (EXAC) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Traws Pharma (TRAW) Tops Q2 EPS by 27c
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c